M. Scott Perry, MD

Articles

M. Scott Perry, MD: Clinical Experience With Fenfluramine in Dravet Syndrome

April 26, 2020

The co-director of the Jane and John Justin Neurosciences Center at Cook Children’s Hospital discussed his experience with Zogenix’s investigational Dravet syndrome treatment in clinical trials and in the Expanded Access Program.

M. Scott Perry, MD: Real-World Fenfluramine Data in Dravet Syndrome

April 25, 2020

The co-director of the Jane and John Justin Neurosciences Center at Cook Children’s Hospital discussed the real-world data collected from the Expanded Access Program for fenfluramine (Fintepla; Zogenix) in patients with Dravet syndrome.